Assorted News from the Last Week:  How wearable devices are empowering childhood cancer survivors. Improving fever management of hospitalized children with cancer: Barriers, facilitators, and

Assorted News from the Last Week:  CAC2 Student Member and Rookie-of-the Year Joshua Omale published on the global rise in young-onset cancers and the role

Assorted News from the Last Week: CAC2 Supporting Organization Jazz Pharmaceuticals announced that the FDA granted accelerated approval for Modeyso™ (dordaviprone) for the treatment of

Assorted News from the Last Week: Scoping review of the utilization of wearable devices in pediatric and young adult oncology Engineered L-asparaginase variants with enhanced

Assorted News from the Last Week: Researchers at the University of Florida are moving closer to developing what they have described as a “universal” cancer

Assorted News from the Last Week: Muscle weakness in cancer survivors may be caused by treatable weakness in blood vessels. An aggressive childhood cancer case

Assorted News from the Last Week: Survival rates for cancer patients on immunotherapy depend on insurance coverage: Those on private insurance or Medicaid had higher survival

Assorted News from the Last Week: CAC2 Guest Blog Post–The National Cancer Institute (NCI) will host the CCDI Symposium this October and bring together the

Assorted News from the Last Week: Nutritional status, body composition, and chemotherapy dosing in children and young people with cancer: a systematic review by the

Assorted News from the Last Week: CAC2 sends childhood cancer survivors a Thank You note. Targeting fusion protein’s role in childhood leukemia produces striking results.